[HTML][HTML] Adverse cognitive effects of glucocorticoids: a systematic review of the literature

L Spannenburg, H Reed - Steroids, 2023 - Elsevier
Objectives Glucocorticoids as a drug class are widely used in the treatment of many
conditions including more recently as one of the mainstay treatments for the SARS-CoV-2 …

Systemic and targeted steroids for the treatment of IgA nephropathy

F Locatelli, L Del Vecchio, C Ponticelli - Clinical Kidney Journal, 2023 - academic.oup.com
Immunoglobulin A nephropathy (IgAN) is a common glomerulonephritis partially correlated
with mucosal immune system dysfunction. Progressive renal failure occurs in many patients …

[HTML][HTML] The polarization of M2 macrophages can be adjusted to alleviate renal injury by methylprednisolone in sepsis-AKI

K Ma, JF Liu, ZR Zheng, HY Li, B Hu, Y Meng - Archives of Biochemistry …, 2023 - Elsevier
Acute kidney injury in sepsis patients has an extreme mortality rate in clinical. It obviously
seems that immune cells, for example, macrophages are involved with this process …

Drugs in Development to Treat IgA Nephropathy

L Del Vecchio, M Allinovi, S Comolli, S Peiti, C Rimoldi… - Drugs, 2024 - Springer
IgA nephropathy is a common glomerulonephritis consequent to the autoimmune response
to aberrant glycosylated immunoglobulin (Ig) A antibodies. Although it has historically been …

Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?

F Locatelli, E Paoletti, M Ravera… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction In recent years, thanks to significant advances in basic science and
biotechnologies, nephrology has witnessed a deeper understanding of the mechanisms …

[HTML][HTML] Prognosis of IgA Nephropathy with Stages 3b-5 CKD

Z Wu, H Li, Y Liu, F Wang, Y Xing, W Li, J Jia… - Kidney and Blood …, 2024 - karger.com
Introduction: There are conflicting opinions regarding the use of immunosuppressant
treatment in IgA nephropathy (IgAN) patients with an estimated glomerular filtration rate …

Comparative effectiveness and safety for the treatments despite optimized renin-angiotensin system blockade among IgA nephropathy patients at high-risk of disease …

Q Tan, H Xue, X Ni, L Fan, W Du - European Journal of Internal Medicine, 2023 - Elsevier
Abstract Objective Approximately 20–40% of IgA nephropathy patients would develop end-
stage renal disease, for whom safety concerns remained a major setback when using …

Diagnosing and Treating IgAN: Steroids, Budesonide, or Maybe Both?

C Keskinis, E Moysidou, M Christodoulou, P Pateinakis… - Diagnostics, 2024 - mdpi.com
IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, is
characterized by a mesangial IgA deposit and a variety of histological lesions, as described …

Comprehensive analysis of ceRNA network and immune cell infiltration pattern of autophagy related genes in IgA nephropathy

H Zhang, H Lu, B Zhan, H Shi, B Shui - Kidney & blood pressure …, 2024 - karger.com
Abstract Introduction: IgA nephropathy (IgAN) is a prevalent worldwide glomerular disease
with a complex pathophysiology that has significant economic implications. Despite the lack …

Clinical Efficacy of Huangkui Capsule Plus Methylprednisolone for Immunoglobulin A Nephropathy and Its Effect on Renal Function and Serum Inflammatory Factors

L Yuan, K Cai, Y Zou - Evidence‐Based Complementary and …, 2023 - Wiley Online Library
Objective. To assess the clinical efficacy of Huangkui capsule plus methylprednisolone for
immunoglobulin A (IgA) nephropathy and its effect on renal function and serum inflammatory …